Of note, treatment with scFvFITC:sFasL induced significant apoptosis in 3 out of 3 primary patient-derived melanoma cells pretargeted with anti-MCSP-FITC, whereas no significant increase in apoptosis was observed in cells pretargeted with anti-CD14-FITC (Fig. 4G). This evidence concerns the gene CD14 and melanoma.